Bronconex Acticap

Nchi: Nyuzilandi

Lugha: Kiingereza

Chanzo: Medsafe (Medicines Safety Authority)

Viambatanisho vya kazi:

Mometasone furoate 400ug (anhydrous)

Inapatikana kutoka:

Organon (New Zealand) Limited

INN (Jina la Kimataifa):

Mometasone furoate 400 µg (anhydrous)

Kipimo:

400 mcg/dose

Dawa fomu:

Powder for inhalation

Tungo:

Active: Mometasone furoate 400ug (anhydrous) Excipient: Lactose

Vitengo katika mfuko:

Inhaler, metered, DPI, (sample), 14 dose units

Darasa:

Prescription

Dawa ya aina:

Prescription

Viwandani na:

MSD International GmbH (Singapore Branch)

Matibabu dalili:

Bronconex Acticap is indicated for prophylactic therapy in the management of patients with asthma of all severities, including patients who have been dependent upon either inhaled or systemically administered corticosteroids and non-corticosteroid-dependent patients inadequately controlled on other drug regimens.

Bidhaa muhtasari:

Package - Contents - Shelf Life: Inhaler, metered, DPI, (sample) - 14 dose units - 18 months from date of manufacture stored at or below 25°C - Inhaler, metered, DPI - 30 dose units - 18 months from date of manufacture stored at or below 25°C - Inhaler, metered, DPI - 60 dose units - 18 months from date of manufacture stored at or below 25°C

Idhini ya tarehe:

2000-12-05